Cargando…
Review of Regional Therapies for Gastric Cancer with Peritoneal Metastases
SIMPLE SUMMARY: Gastric cancer is usually diagnosed at late stages and is associated with poor five-year survival rates. Metastasis to the peritoneal cavity is common and leads to even worse outcomes. Currently, the mainstay of treatment for metastatic gastric cancer is systemic chemotherapy or supp...
Autores principales: | Sun, Beatrice J., Lee, Byrne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833629/ https://www.ncbi.nlm.nih.gov/pubmed/35158837 http://dx.doi.org/10.3390/cancers14030570 |
Ejemplares similares
-
The Role of Prophylactic and Adjuvant Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Prevention of Peritoneal Metastases in Advanced Colorectal Cancer
por: Sun, Beatrice J., et al.
Publicado: (2023) -
Treatment of patients with peritoneal metastases from gastric cancer
por: Kitayama, Joji, et al.
Publicado: (2018) -
Gastric Cancer with Peritoneal Metastases: Current Status and Prospects for Treatment
por: Manzanedo, Israel, et al.
Publicado: (2023) -
The Burden of Peritoneal Metastases from Gastric Cancer: A Systematic Review on the Incidence, Risk Factors and Survival
por: Rijken, Anouk, et al.
Publicado: (2021) -
Prevention and Treatment of Peritoneal Metastases from Gastric Cancer
por: Sugarbaker, Paul H.
Publicado: (2021)